Partners Innovation Fund, LLC 4

4 · Akouos, Inc. · Filed Jul 2, 2020

Form 4Exit

Period: 2020-06-30

10% Owner

Transactions

Conversion
Common Stock
[F1][F2]
2020-06-30+102,751→ 102,751 total
Conversion
Common Stock
[F3][F2]
2020-06-30+342,505→ 445,256 total
Conversion
Common Stock
[F4][F2]
2020-06-30+119,997→ 565,253 total
Conversion
Series Seed Preferred Stock
[F1][F2]
2020-06-30−102,751→ 0 total
→ Common Stock (102,751 underlying)
Conversion
Series A Preferred Stock
[F3][F2]
2020-06-30−342,505→ 0 total
→ Common Stock (342,505 underlying)
Conversion
Series B Preferred Stock
[F4][F2]
2020-06-30−119,997→ 0 total
→ Common Stock (119,997 underlying)

Footnotes (4)

[F1]On June 30, 2020, the Series Seed Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
[F2]The securities are held by Partners Innovation Fund, LLC ("PIF"). PIF is a limited liability company controlled by its members. The Members of PIF are (1) The General Hospital Corporation (commonly referred to as "MGH"), (2) Brigham and Women's Hospital and (3) Massachusetts Eye and Ear.
[F3]On June 30, 2020, the Series A Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
[F4]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.

Signature

/s/ Partners Innovation Fund, LLC By: Julius Knowles, Authorized Signatory|2020-07-02

Documents

1 file